Einträge von Wild, Peter auf dem Publikationsserver

Jonigk, Danny, Werlein, Christopher, Acker, Till, Aepfelbacher, Martin, Amann, Kerstin U., Baretton, Gustavo, Barth, Peter, Bohle, Rainer M., Büttner, Andreas, Büttner, Reinhard, Dettmeyer, Reinhard, Eichhorn, Philip, Elezkurtaj, Sefer , Esposito, Irene, Evert, Katja , Evert, Matthias, Fend, Falko, Gaßler, Nikolaus, Gattenlöhner, Stefan, Glatzel, Markus, Göbel, Heike , Gradhand, Elise, Hansen, Torsten, Hartmann, Arndt, Heinemann, Axel, Heppner, Frank L. , Hilsenbeck, Julia, Horst, David, Kamp, Jan C. , Mall, Gita, Märkl, Bruno, Ondruschka, Benjamin, Pablik, Jessica, Pfefferle, Susanne, Quaas, Alexander, Radbruch, Helena , Röcken, Christoph, Rosenwald, Andreas, Roth, Wilfried, Rudelius, Martina, Schirmacher, Peter, Slotta-Huspenina, Julia, Smith, Kevin, Sommer, Linna , Stock, Konrad, Ströbel, Philipp, Strobl, Stephanie, Titze, Ulf, Weirich, Gregor, Weis, Joachim, Werner, Martin, Wickenhauser, Claudia, Wiech, Thorsten, Wild, Peter , Welte, Tobias, von Stillfried, Saskia und Boor, Peter (2022) Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Virchows Archiv 481 (2), S. 139-159.

Morshaeuser, Laura, May, Matthias, Burger, Maximilian, Otto, Wolfgang, Hutterer, Georg C., Pichler, Martin, Klatte, Tobias, Wild, Peter, Buser, Lorenz und Brookman-May, Sabine (2018) p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urologic Oncology: Seminars and Original Investigations 36 (3), 94.e15-94.e21. Volltext nicht vorhanden.

Wulfänger, Jens, Biehl, Katharina, Tetzner, Anja, Wild, Peter, Ikenberg, Kristian, Meyer, Stefanie und Seliger, Barbara (2013) Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma. International Journal of Cancer, n/a-n/a. Volltext nicht vorhanden.

Wulfänger, Jens, Schneider, Heike, Wild, Peter, Ikenberg, Kristian, Rodolfo, Monica , Rivoltini, Licia , Meyer, Stefanie, Riemann, Dagmar und Seliger, Barbara (2012) Promoter methylation of aminopeptidase N/CD13 in malignant melanoma. Carcinogenesis 33 (4), S. 781-790. Volltext nicht vorhanden.

Kirovski, Georgi, Stevens, Axel Peter, Czech, Barbara, Dettmer, Katja , Weiss, Thomas S. , Wild, Peter, Hartmann, Arndt, Bosserhoff, Anja-Katrin , Oefner, Peter J. und Hellerbrand, Claus (2011) Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). The American journal of pathology 178 (3), S. 1145-1152. Volltext nicht vorhanden.

Mauerer, Andreas, Roesch, Alexander, Hafner, Christian, Stempfl, Thomas, Wild, Peter, Meyer, Stefanie, Landthaler, Michael und Vogt, Thomas (2011) Identification of new genes associated with melanoma. Experimental Dermatology 20 (6), S. 502-507. Volltext nicht vorhanden.

Gluz, Oleg, Wild, Peter, Liedtke, Cornelia, Kates, Ronald, Mendrik, Heiko, Ehm, Elisabeth, Artinger, Verena, Diallo-Danebrock, Raihanatou, Ting, Evelyn, Mohrmann, Svjetlana, Poremba, Christopher, Harbeck, Nadia, Nitz, Ulrike, Hartmann, Arndt und Gaumann, Andreas (2011) Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial. Breast Cancer Research and Treatment 126 (3), S. 643-651. Volltext nicht vorhanden.

Ikenberg, Kristian, Fritzsche, Florian R., Zuerrer-Haerdi, Ursina, Hofmann, Irina, Hermanns, Thomas, Seifert, Helge, Müntener, Michael, Provenzano, Maurizio, Sulser, Tullio, Behnke, Silvia, Gerhardt, Josefine, Mortezavi, Ashkan, Wild, Peter, Hofstädter, Ferdinand, Burger, Maximilian, Moch, Holger und Kristiansen, Glen (2010) Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer 10 (341), S. 1-6.

Hoffmann, Andreas-Claudius , Wild, Peter, Leicht, Christina, Bertz, Simone, Danenberg, Kathleen D., Danenberg, Peter V., Stöhr, Robert, Stöckle, Michael, Lehmann, Jan, Schuler, Martin und Hartmann, Arndt (2010) MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy. Neoplasia 12 (8), S. 628-636. Volltext nicht vorhanden.

Massoumi, Ramin, Kuphal, Silke, Hellerbrand, Claus, Haas, Bodo , Wild, Peter, Spruss, Thilo, Pfeifer, Alexander, Fässler, Reinhard und Bosserhoff, Anja K. (2009) Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. Journal of Experimental Medicine 206 (1), S. 221-232. Volltext nicht vorhanden.

Riener, Marc-Oliver, Stenner, Frank , Liewen, Heike, Soll, Christopher, Breitenstein, Stefan, Pestalozzi, Bernhard Cornelius, Samaras, Panagiotis, Probst-Hensch, Nicole, Hellerbrand, Claus, Müllhaupt, Beat, Clavien, Pierre-Alain, Bahra, Marcus, Neuhaus, Peter, Wild, Peter, Fritzsche, Florian, Moch, Holger, Jochum, Wolfram und Kristiansen, Glen (2009) Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas #. Hepatology 49 (5), S. 1602-1609. Volltext nicht vorhanden.

Fritzsche, Florian R., Jung, Monika , Tölle, Angelika, Wild, Peter, Hartmann, Arndt, Wassermann, Kirsten, Rabien, Anja, Lein, Michael, Dietel, Manfred, Pilarsky, Christian , Calvano, Daniela, Grützmann, Robert, Jung, Klaus und Kristiansen, Glen (2008) ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer. European Urology 54 (5), S. 1097-1108. Volltext nicht vorhanden.

Sassen, Andrea, Rochon, Justine, Wild, Peter, Hartmann, Arndt, Hofstädter, Ferdinand, Schwarz, Stephan und Brockhoff, Gero (2008) Cytogenetic analysis of HER1 / EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast cancer research. Volltext nicht vorhanden.

Sassen, Andrea, Rochon, Justine, Wild, Peter, Hartmann, Arndt, Hofstaedter, Ferdinand, Schwarz, Stephan und Brockhoff, Gero (2008) Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast Cancer Research 10 (1). Volltext nicht vorhanden.

Gluz, Oleg, Wild, Peter, Meiler, Robert, Diallo‐Danebrock, Raihana, Ting, Evelyn, Mohrmann, Svjetlana, Schuett, Gerhart, Dahl, Edgar, Fuchs, Thomas, Herr, Alexander, Gaumann, Andreas, Frick, Markus, Poremba, Christopher, Nitz, Ulrike Anneliese und Hartmann, Arndt (2008) Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. International Journal of Cancer 123 (6), S. 1433-1438. Volltext nicht vorhanden.

Kasper, Grit, Weiser, Armin A., Rump, Andreas , Sparbier, Katrin, Dahl, Edgar, Hartmann, Arndt, Wild, Peter, Schwidetzky, Uta, Castaños‐Vélez, Esmeralda und Lehmann, Kerstin (2005) Expression levels of the putative zinc transporter LIV‐1 are associated with a better outcome of breast cancer patients. International Journal of Cancer 117 (6), S. 961-973. Volltext nicht vorhanden.

Roesch, Alexander, Becker, Bernd, Meyer, Stefanie, Wild, Peter, Hafner, Christian, Landthaler, Michael und Vogt, Thomas (2005) Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Modern Pathology 18 (9), S. 1249-1257. Volltext nicht vorhanden.

Stoehr, Robert, Wissmann, Christoph, Suzuki, Hiromu, Knuechel, Ruth, Krieg, Rene C., Klopocki, Eva , Dahl, Edgar, Wild, Peter, Blaszyk, Hagen, Sauter, Guido, Simon, Ronald , Schmitt, Ruediger, Zaak, Dirk, Hofstaedter, Ferdinand, Rosenthal, Andre, Baylin, Stephen B., Pilarsky, Christian und Hartmann, Arndt (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Laboratory investigation 84 (4), S. 465-478. Volltext nicht vorhanden.

Stoehr, Robert, Brinkmann, Anke, Filbeck, Thomas, Gamper, Christoph, Wild, Peter, Blaszyk, Hagen, Hofstaedter, Ferdinand, Knuechel, Ruth und Hartmann, Arndt (2004) No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract. Oncology reports 11 (1), S. 137-141. Volltext nicht vorhanden.

Stoehr, Robert, Brinkmann, Anke, Filbeck, Thomas, Gamper, Christoph, Wild, Peter, Blaszyk, Hagen, Hofstaedter, Ferdinand, Knuechel, Ruth und Hartmann, Arndt (2004) No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract. Oncology Reports. Volltext nicht vorhanden.

Reichle, Albrecht, Bross, Klaus, Vogt, Thomas, Bataille, Frauke, Wild, Peter, Berand, Anna, Krause, Stefan W. und Andreesen, Reinhard (2004) Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma. Cancer 101 (10), S. 2247-56. Volltext nicht vorhanden.

Reichle, A., Bolder, U., Bataille, F., Messmann, H., Wagner, H., Zaiss, M., Wild, Peter, Hofstädter, Ferdinand, Andreesen, Reinhard und Jauch, K.-W. (2003) A multimodal treatment approach including high-dose chemotherapy in very advanced gastric cancer: evidence for control of metastatic disease. Bone marrow transplantation 32 (7), S. 665-671. Volltext nicht vorhanden.

Bataille, Frauke, Klebl, Frank, Rümmele, Petra, Straub, Rainer H. , Wild, Peter, Schölmerich, Jürgen und Hofstädter, Ferdinand (2003) Histopathological parameters as predictors for the course of Crohn's disease. Virchows Archiv: an international journal of pathology 443 (4), S. 501-507. Volltext nicht vorhanden.

Stoehr, Robert, Wild, Peter und Hartmann, Arndt (2003) Lasermicrodissection – An Important Prerequisite for the Molecular-genetic Analysis of Bladder Cancer. Pathology - Research and Practice 199 (6), S. 355-362. Volltext nicht vorhanden.